Synthesis and evaluation of antibacterial activity of novel 3-methyl-1H-indazole derivatives

Abstract

Aim of the study was designed to synthesize and evaluate antibacterial activity of novel heterocyclic compounds, 3-methyl-1H-indazole derivatives. The heterocyclic compounds, 3-methyl-1H-indazole derivatives (1a-1d and 2a- 2d) were synthesized; all of them characterized physically by melting point, R_f value, appearance & solubility; and some of them characterized spectroscopically by IR and ¹H NMR spectroscopy. All the synthesized derivatives were evaluated for their antibacterial activity against both Gram positive bacteria, Bacillus subtilis and Gram negative bacteria, Escherichia coli by cup plate method using ciprofloxacin as a standard drug. All the synthesized heterocyclic compounds, 3-methyl-1H-indazole derivatives (1a-1d and 2a-2d), had shown antibacterial activity against the B. subtilis and E. coli. Compound 1d i.e., 1-(2-(piperidin-1-yl)ethan-1-oyl)-3-methyl-1H-indazole at the concentration of 300 µg/ml showed best antibacterial activity against the bacteria B. subtilis and E. coli as compared to standard drug, ciprofloxacin. The methodology for the synthesis of heterocyclic compounds, 3- methyl-1H-indazol-1-yl derivatives was simple as well as economical and gave better yield of the synthesized compounds. The compound, 1-(2-(piperidin-1-yl)ethan-1-oyl)-3-methyl-1H-indazole had shown best antibacterial activity against the bacteria B. subtilis and E. coli.

Keywords

Indazole / Antibacterial activity / Bacillus subtilis / Escherichia coli / Ciprofloxacin

References

[1] Schmidt A, Beutler A, Snovydovych B. Recent advances in the chemistry of indazoles. Eur J Org Chem. 2008;24:4073–4095.

[2] Parekh C, Modi A, Pillai J, Patel B. A novel synthesis of series of indazole derivative as potent antimicrobial agents. International Journal of Drug Research and Technology. 2012;2(3):279–288.

[3] Kumar V, Gupta K, Sirbaiya AK, Rahman MA. A review of indazole derivatives in pharmacotherapy of inflammation. Innovat International Journal of Medical & Pharmaceutical Sciences. 2021;6(5):7–12.

[4] Abu-Hashem AA. Synthesis of new pyrazoles, oxadiazoles, triazoles, pyrrolotriazines, and pyrrolotriazepines as potential cytotoxic agents. J Heterocycl Chem. 2021;58(3):805–821.

[5] Abu-Hashem AA. Synthesis and biological activity of pyrimidines, quinolines, thiazines and pyrazoles bearing a common thieno moiety. Acta Pol Pharm. 2018;75(1):59–70.

[6] Abu-Hashem AA, Gouda MA. Synthesis and antimicrobial activity of some novel quinoline, chromene, pyrazole derivatives bearing triazolopyrimidine moiety. J Heterocycl Chem. 2017;54(2):850–858.

[7] Abu-Hashem AA, El-Shazly M. Synthesis of new quinoxaline, pyrimidine, and pyrazole furochromone derivatives as cytotoxic agents. Monatshefte Für Chemie-Chemical. 2017;148:1853–1863.

[8] Abu-Hashem AA, Aly AS. Synthesis of new pyrazole, triazole, and thiazolidinepyrimido [4, 5-b] quinoline derivatives with potential antitumor activity. Arch Pharm Res (Seoul). 2012;35:437–445.

[9] Fathy U, Abu-Hashem AA, Gouhar RS, Awad HM, Elgamal AM. Synthesis, structural characterization of some pyrazolo [1-5a] pyrimidine and imidazo [1, 2-b]-pyrazole derivatives as anticancer activity. Rasyan J. Chem. 2021;14:741–750.

[10] Abu-Hashem AA, Al-Hussain SA, Zaki ME. Design, synthesis and anticancer activity of new polycyclic: imidazole, thiazine, oxathiine, pyrrolo-quinoxaline and thienotriazolopyrimidine derivatives. Molecules. 2021;26(7):2031.

[11] Sahu PK, Sahu PK, Gupta SK, Thavaselvam D, Agarwal DD. Synthesis and evaluation of antimicrobial activity of 4H-pyrimido[2, 1-b] benzothiazole, pyrazole and benzylidene derivatives of curcumin. Eur J Med Chem. 2012;54:366–378.

[12] Bagga P, Ansari TM, Siddiqui HH, et al. Bromelain capped gold nanoparticles as the novel drug delivery carriers to aggrandize effect of the antibiotic levofloxacin. EXCLI Journal. 2016;15:772–780.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.